(Q47584504)
Statements
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival (English)
William J Gradishar
Dimitry Krasnojon
Sergey Cheporov
Anatoly N Makhson
Georgiy M Manikhas
Alicia Clawson
Paul Bhar
John R McGuire
Jose Iglesias
23 June 2012
12
313-321